Imbruvica Shows Response in 2/3 of Steroid Dependent, Refractory cGVHD Patients in Phase II Study December 22, 2016Vol.39 No.11
Tagrisso Shows Superiority vs. Chemo in EGFR T790M Mutation-Positive Disease December 22, 2016Vol.39 No.11
Study met Primary Endpoint of Non-Inferiority Versus Zoledronic Acid in Delaying Skeletal-Related Events November 29, 2016Vol.39 No.10
High-Dose Chemo and Stem Cell Transplant Cures Most Relapsed Testis Cancer November 29, 2016Vol.39 No.10
Positive Survival Results from Apatorsen Phase II Trial in Metastatic Bladder Cancer November 29, 2016Vol.39 No.10
New Evidence-Based Guideline on HER2 Testing for Patients with Gastric Cancer November 29, 2016Vol.39 No.10
Nektar Phase II Study: Anti-tumor activity in 7/18 evaluable patients with solid tumors November 29, 2016Vol.39 No.10
